NBSE — NEUBASE THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
NBSE (NEUBASE THERAPEUTICS INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 26 funds have reported positions historically, with the sum of their latest reported stakes valued at $415.20K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
Major shareholders of NEUBASE THERAPEUTICS INC (NBSE) include Arrowstreet Capital, DME Capital Management, LP, Renaissance Technologies, ranked by reported 13F value among the 26 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q2 2024 | 1 | 16.09K | $4.95K | — |
| Q1 2024 | 16 | 391.99K | $176.54K | -10.6% |
| Q4 2023 | 19 | 323.50K | $249.25K | -1.0% |
| Q3 2023 | 17 | 193.91K | $168.66K | +4.0% |
| Q2 2023 | 10 | 107.28K | $200.80K | -94.7% |
| Q1 2023 | 5 | 1.48M | $273.72K | -7.3% |
| Q4 2022 | 6 | 1.83M | $347.27K | -0.1% |
| Q3 2022 | 3 | 1.59M | $630.00K | +3.1% |
Over the 8 quarters shown, institutional share counts decreased 99% in aggregate (Q3 2022 → Q2 2024); the largest single-quarter swing was Q2 2023 (-94.7%).
Top Institutional Holders (Q2 2024) — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 16.09K | $4.95K | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q1 2024 — 16 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 136.35K | $61.34K | 0.00% | New | |
| 88.23K | $40.00K | 0.00% | Add | |
| 62.50K | $28.12K | 0.00% | Hold | |
| 46.97K | $21.13K | 0.03% | Hold | |
| 18.98K | $8.54K | 0.00% | Hold | |
| 15.55K | $7.00K | 0.00% | Hold | |
| 15.48K | $6.84K | 0.00% | Hold | |
| 4.06K | $1.82K | 0.00% | Reduce | |
| 2.57K | $1.16K | 0.00% | Add | |
| 804 | $361 | 0.00% | Hold | |
| 353 | $158 | 0.00% | Hold | |
| 79 | $35 | 0.00% | Hold | |
| 22 | $10 | 0.00% | Hold | |
| 21 | $9 | 0.00% | Hold | |
| 12 | $5 | 0.00% | Hold | |
| 9 | $4 | 0.00% | Hold |
Q4 2023 — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 65.72K | $48.63K | 0.00% | New | |
| 62.50K | $46.26K | 0.00% | Hold | |
| 56.97K | $42.00K | 0.00% | New | |
| 46.97K | $34.76K | 0.04% | Hold | |
| 21.08K | $15.60K | 0.00% | New | |
| 18.98K | $14.05K | 0.00% | Hold | |
| 16.48K | $12.19K | 0.00% | Reduce | |
| 15.55K | $11.51K | 0.00% | Hold | |
| 15.48K | $11.46K | 0.00% | Hold | |
| 7 | $10.00K | 0.00% | Reduce | |
| 2.45K | $1.81K | 0.00% | Add | |
| 804 | $595 | 0.00% | Hold | |
| 353 | $261 | 0.00% | Reduce | |
| 79 | $58 | 0.00% | Add | |
| 21 | $16 | 0.00% | Hold | |
| 22 | $16 | 0.00% | Hold | |
| 12 | $9 | 0.00% | Hold | |
| 12 | $9 | 0.00% | Hold | |
| 9 | $6 | 0.00% | Hold |
Q3 2023 — 17 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 62.50K | $54.36K | 0.00% | Hold | |
| 46.97K | $40.85K | 0.05% | New | |
| 18.98K | $16.51K | 0.00% | Hold | |
| 17.98K | $15.64K | 0.00% | New | |
| 15.55K | $13.53K | 0.00% | New | |
| 15.48K | $13.47K | 0.00% | Add | |
| 12.35K | $10.75K | 0.00% | New | |
| 2.43K | $2.12K | 0.00% | New | |
| 804 | $698 | 0.00% | Hold | |
| 706 | $614 | 0.00% | New | |
| 65 | $56 | 0.00% | Add | |
| 22 | $19 | 0.00% | New | |
| 21 | $18 | 0.00% | Hold | |
| 12 | $10 | 0.00% | New | |
| 12 | $10 | 0.00% | New | |
| 10 | $9 | 0.00% | New | |
| 9 | $8 | 0.00% | Add |
Q2 2023 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 62.50K | $116.88K | 0.00% | Reduce | |
| 18.98K | $35.49K | 0.00% | New | |
| 12.60K | $24.00K | 0.00% | Reduce | |
| 11.70K | $21.64K | 0.00% | New | |
| 804 | $1.50K | 0.00% | New | |
| 539 | $997 | 0.00% | New | |
| 68 | $127 | 0.00% | New | |
| 62 | $116 | 0.00% | Reduce | |
| 21 | $39 | 0.00% | Reduce | |
| 7 | $13 | 0.00% | New |
Q1 2023 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.25M | $231.25K | 0.00% | Hold | |
| 172.63K | $32.00K | 0.00% | Reduce | |
| 54.93K | $10.16K | 0.00% | Hold | |
| 1.24K | $229 | 0.00% | Reduce | |
| 427 | $79 | 0.00% | Hold |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baader Bank Aktiengesellschaft | 16.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | 88.23K | 56.97K | — | 12.60K | 172.63K | 285.22K | 287.39K | 239.13K | 214.84K | 122.39K | 391.19K | 424.85K | 195.88K | 422.38K | 556.73K | 896.08K | 381.48K | 353.20K | 257.52K |
| Point72 Asset Management | — | 62.50K | 62.50K | 62.50K | 62.50K | 1.25M | 1.25M | 1.25M | 1.25M | 1.25M | 1.25M | 1.25M | 1.25M | — | — | — | — | — | — | — |
| Northern Trust Corp | — | — | — | — | — | 54.93K | 54.93K | 54.93K | 54.93K | 54.93K | 54.93K | 54.93K | 54.93K | 182.29K | 198.25K | 194.75K | 194.00K | — | — | — |
| Arrowstreet Capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 22.70K | 54.70K | — | — | — | — |
| Wells Fargo & Co | — | 79 | 79 | 65 | 62 | 1.24K | 5.23K | — | — | — | 190 | 190 | 194 | 6.27K | 32.83K | 30.15K | 25.03K | 641 | — | — |
| DME Capital Management, LP | — | 136.35K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | — | 4.06K | 65.72K | — | 68 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CARNEGIE MELLON UNIVERSITY | — | 46.97K | 46.97K | 46.97K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Legal & General Investment Management America | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.98K | 2.17K | 2.17K | 2.85K | — | — | — |
| Vanguard Group | — | 18.98K | 18.98K | 18.98K | 18.98K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kestra Advisory Services, LLC | — | — | 16.48K | 17.98K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Two Sigma Investments | — | — | 21.08K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PRELUDE CAPITAL MANAGEMENT, LLC | — | 15.55K | 15.55K | 15.55K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | — | 15.48K | 15.48K | 15.48K | 11.70K | — | 233.97K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | — | — | — | 12.35K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | — | — | 7 | 10 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | — | 2.57K | 2.45K | 2.43K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PNC Financial Services | — | 21 | 21 | 21 | 21 | 427 | 427 | — | — | 427 | 427 | 427 | 427 | — | — | — | — | — | — | — |
| Bank of America Corp | — | 804 | 804 | 804 | 804 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
FAQ
Which funds hold NBSE?
26 funds have reported positions in NBSE across five years of 13F filings; the sum of their latest reported stakes is $415.20K.
Who are the top institutional holders of NBSE?
The largest 13F holders are Arrowstreet Capital, DME Capital Management, LP, Renaissance Technologies, Point72 Asset Management, CARNEGIE MELLON UNIVERSITY; the top 25 are ranked at the top of this page.
Who are the major shareholders of NEUBASE THERAPEUTICS INC?
The major shareholders of NEUBASE THERAPEUTICS INC (NBSE) by reported 13F value are Arrowstreet Capital, DME Capital Management, LP, Renaissance Technologies, Point72 Asset Management, CARNEGIE MELLON UNIVERSITY, among 26 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.